首站-论文投稿智能助手
典型文献
Ferroptosis and its emerging roles in acute pancreatitis
文献摘要:
Acute pancreatitis (AP) is a common and potentially life-threatening pancreatic inflammatory disease. Although it is usually self-limiting, up to 20% of patients will develop into severe AP. It may lead to systemic inflammatory response syndrome and multiple organ dysfunction, affecting the lungs, kidneys, liver, heart, etc. Surviving patients usually have sequelae of varying degrees, such as chronic hyperglycemia after AP (CHAP), pancreatic exocrine insufficiency, and chronic pancreatitis. Lacking specific target treatments is the main reason for high mortality and morbidity, which means that more research on the pathogenesis of AP is needed. Ferroptosis is a newly discovered regulated cell death (RCD), originally described in cancer cells, involving the accumulation of iron and the depletion of plasma membrane polyunsaturated fatty acids, and a caspase-independent RCD. It is closely related to neurological diseases, myocardial infarction, ischemia/reperfusion injury, cancer, etc. Research in the past years has also found the effects of ferroptosis in AP, pancreatic cancer, and AP complications, such as acute lung injury and acute kidney injury. This article reviews the research progress of ferroptosis and its association with the pathophysiological mechanisms of AP, trying to provide new insight into the pathogenesis and treatment of AP, facilitating the development of better-targeted drugs.
文献关键词:
Acute pancreatitis;Ferroptosis;RCD;Autophagy;GPX4;PUFAs;Regulated cell death
作者姓名:
Li Hongyao;Lin Yujie;Zhang Ling;Zhao Jing;Li Peiwu
作者机构:
Department of Emergency, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, Gansu 730030, China
引用格式:
[1]Li Hongyao;Lin Yujie;Zhang Ling;Zhao Jing;Li Peiwu-.Ferroptosis and its emerging roles in acute pancreatitis)[J].中华医学杂志(英文版),2022(17):2026-2034
A类:
Lacking
B类:
Ferroptosis,its,emerging,roles,acute,pancreatitis,Acute,common,potentially,life,threatening,pancreatic,inflammatory,Although,usually,self,limiting,up,patients,will,into,severe,It,may,lead,systemic,response,syndrome,multiple,organ,dysfunction,affecting,lungs,kidneys,liver,heart,etc,Surviving,have,sequelae,varying,degrees,such,chronic,hyperglycemia,after,CHAP,exocrine,insufficiency,specific,treatments,main,reason,high,mortality,morbidity,which,means,that,more,research,pathogenesis,needed,newly,discovered,regulated,death,RCD,originally,described,cancer,cells,involving,accumulation,iron,depletion,plasma,membrane,polyunsaturated,fatty,acids,caspase,independent,closely,related,neurological,diseases,myocardial,infarction,ischemia,reperfusion,injury,Research,past,years,has,also,found,effects,ferroptosis,complications,This,article,reviews,progress,association,pathophysiological,mechanisms,trying,provide,insight,facilitating,development,better,targeted,drugs,Autophagy,GPX4,PUFAs,Regulated
AB值:
0.639003
相似文献
Iron metabolism, ferroptosis, and lncRNA in cancer:knowns and unknowns
Lei QU;Xinyu HE;Qian TANG;Xiao FAN;Jian LIU;Aifu LIN-MOE Laboratory of Biosystem Homeostasis and Protection,College of Life Sciences,Zhejiang University,Hangzhou 310058,China;Cancer Center,Zhejiang University,Hangzhou 310058,China;Key Laboratory for Cell and Gene Engineering of Zhejiang Province,Hangzhou 310058,China;Zhejiang University-University of Edinburgh Institute(ZJU-UoE Institute),Zhejiang University School of Medicine,Zhejiang University,Haining 314400,China;Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province,Affiliated Hangzhou First People's Hospital,Cancer Center,Zhejiang University School of Medicine,Hangzhou 310006,China;College of Medicine and Veterinary Medicine,the University of Edinburgh,Edinburgh EH164SB,UK;Biomedical and Health Translational Research Center of Zhejiang Province,Haining 314400,China;Breast Center of the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;International School of Medicine,International Institutes of Medicine,the Fourth Affiliated Hospital,Zhejiang University School of Medicine,Yiwu 322000,China;ZJU-QILU Joint Research Institute,Hangzhou 310058,China
Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis
Fang Wang;Jia-nan Wang;Xiao-yan He;Xiao-guo Suo;Chao Li;Wei-jian Ni;Yu-ting Cai;Yuan He;Xin-yun Fang;Yu-hang Dong;Tian Xing;Ya-ru Yang;Feng Zhang;Xiang Zhong;Hong-mei Zang;Ming-ming Liu;Jun Li;Xiao-ming Meng;Juan Jin-Inflammation and Immune Mediated Diseases Laboratory of Anhui Province,Anhui Institute of Innovative Drugs,School of Pharmacy,Anhui Medical University,The Key Laboratory of Anti-inflammatory of Immune Medicines,Ministry of Education,Hefei 230032,China;Department of Pharmacy,Anhui Provincial Hospital,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230001,China;Hospital of Stomatology,Anhui Medical University,Key Laboratory of Oral Diseases Research of Anhui Province,Hefei 230032,China;Department of Pharmacy,Changzheng Hospital,Naval Medical University,Shanghai 200003,China;Department of Nephrology,Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610072,China;School of Basic Medical Sciences,Anhui Medical University,Hefei 230032,China
Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury
Chao Deng;Lin Zhao;Zhi Yang;Jia-jia Shang;Chang-yu Wang;Ming-zhi Shen;Shuai Jiang;Tian Li;Wen-cheng Di;Ying Chen;He Li;Ye-dong Cheng;Yang Yang-Xi'an Key Laboratory of Cardiovascular and Cerebrovascular Diseases,Xi'an No.3 Hospital,School of Life Sciences and Medicine,Northwest University,Xi'an 710021,China;Department of Orthopaedics,Huaian Medical District of Jingling Hospital,Medical School of Nanjing University,Huaian 213001,China;Department of Cardiovascular Surgery,The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China;Department of Cardiovascular Surgery,Xijing Hospital,The Fourth Military Medical University,Xi'an 710032,China;Key Laboratory of Resource Biology and Biotechnology in Western China,Ministry of Education.Life of Sciences,Northwest University,Xi'an 710021,China;Department of Cardiology,Xi'an No.3 Hospital,School of Life Sciences and Medicine,Northwest University,Xi'an 710021,China;Hainan Hospital of PLA General Hospital,The Second School of Clinical Medicine,Southern Medical University,Sanya 572013,China;National Clinical Research Center for Infectious Diseases,Shenzhen Third People's Hospital,Southern University of Science and Technology,Shenzhen 518100,China;Department of Hematology,The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China
NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
Zhi-yong Xie;Wei Dong;Li Zhang;Meng-jie Wang;Zhen-meng Xiao;Yu-hua Zhang;Wan-xin Shi;Ying Huang;Yan Yang;Cui-li Li;Lei Fu;Xing-chen Zhao;Rui-zhao Li;Zhi-lian Li;Yuan-han Chen;Zhi-ming Ye;Shuang-xin Liu;Zheng Dong;Xin-ling Liang-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Division of Nephrology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;School of Medicine,South China University of Technology,Guangzhou 510006,China;Department of Cellular Biology and Anatomy,Medical College of Georgia at Augusta University,Augusta,GA,USA;Department of Medical Research,Charlie Norwood Veterans Affairs Medical Center,Augusta,GA,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。